A major Australian convenience store and petrol station retailer says it would be happy to train staff to suggest e-cigarettes as an alternative to normal cigarettes in a bid to help reduce the smoking rate.
Ampol, owner of Caltex and Foodary outlets across the country, urged the government to allow nicotine-based vaping products to be sold in the same way as cigarettes in its submission to a Senate inquiry.
On Friday, the Senate select committee on tobacco harm reduction will hold its first public hearing into nicotine vaping products, which currently can be legally purchased only with a doctor’s prescription.
Committee chair Hollie Hughes said the more than 8000 submissions had been overwhelmingly supportive of vaping and “overwhelmingly not in favour of a script model”.
“I would like to see recommendations around very serious regulation,” she said. “I don’t think anyone is going to be a non-smoker and take it up. I think it’s an incredibly powerful cessation tool and part of [the] discussion of further reducing smoking rates in Australia.”
An Ampol spokesman said the company believed controlled access to e-cigarette produces was a beneficial harm-reduction strategy.
“We believe they should be accessible to existing smokers with the same convenience as cigarettes,” the spokesman said.
In Ampol’s submission, its head of government affairs, Todd Loydell, wrote that the company was well positioned to help cigarette smokers transition to “less harmful products” and was willing to trial selling e-cigarette products through its large network of convenience stores.
“For example, our retail staff could provide a verbal cue to customers who ask to purchase cigarettes, encouraging them to consider the alternative options available to them in store.”
The National Retailers Association, which represents 28,000 retailers across the country, also advocated for a consumer model for vaping regulation.
But the peak body representing health workers in respiratory health advocated for keeping the current prescription-based model. The Thoracic Society of Australia and New Zealand argued current research did not support the use of vaping as a first-line quit-smoking aid, and those products should continue to be managed through the Therapeutic Goods Administration.
This is the second recent inquiry into tobacco harm reduction and nicotine vaping.
After a year-long inquiry, the standing committee on health, aged care and sport recommended in 2018 that the TGA should continue to have oversight of nicotine products.
The now-deputy chair of that committee, Labor MP Dr Mike Freelander, remains strongly opposed to e-cigarettes becoming a consumer product.
On Monday, Dr Freelander, who is also a paediatrician, moved a motion in the House of Representatives condemning the Senate inquiry into vaping.
“I am concerned that this new inquiry is a thinly veiled attempt from big tobacco companies to push their agenda upon our Parliament,” Dr Freelander said. “It is worth noting that the jury is still out on the potential benefits of these products.”
Senator Hughes said big tobacco was the “big loser” with vaping and it was anti-vaping advocates who were in the pocket of tobacco companies.
“People are getting off the cigarettes. Making it harder for people to vape will push people back onto cigarettes,” she said.
Extracted from The Sydney Morning Herald